vs
Kiniksa Pharmaceuticals International, plc（KNSA）与BRC Group Holdings, Inc.（RILY）财务数据对比。点击上方公司名可切换其他公司
Kiniksa Pharmaceuticals International, plc的季度营收约是BRC Group Holdings, Inc.的1.1倍（$202.1M vs $188.3M），BRC Group Holdings, Inc.净利率更高（47.9% vs 7.0%，领先40.9%），Kiniksa Pharmaceuticals International, plc同比增速更快（65.0% vs -21.9%），过去两年Kiniksa Pharmaceuticals International, plc的营收复合增速更高（59.1% vs -15.4%）
Kiniksa Pharmaceuticals International plc是一家全球性生物制药企业，专注于发现、开发和商业化针对自身免疫性疾病、炎症性疾病及罕见病的靶向治疗药物，服务北美、欧洲、亚洲等主要市场的未被满足的临床需求。
KNSA vs RILY — 直观对比
营收规模更大
KNSA
是对方的1.1倍
$188.3M
营收增速更快
KNSA
高出86.8%
-21.9%
净利率更高
RILY
高出40.9%
7.0%
两年增速更快
KNSA
近两年复合增速
-15.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $188.3M |
| 净利润 | $14.2M | $90.3M |
| 毛利率 | 89.6% | 79.5% |
| 营业利润率 | 9.8% | 32.3% |
| 净利率 | 7.0% | 47.9% |
| 营收同比 | 65.0% | -21.9% |
| 净利润同比 | 259.8% | 1710.8% |
| 每股收益（稀释后） | $0.18 | $2.78 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收KNSARILY
| Q4 25 | $202.1M | $188.3M | ||
| Q3 25 | $180.9M | $215.3M | ||
| Q2 25 | $156.8M | $188.2M | ||
| Q1 25 | $137.8M | $197.2M | ||
| Q4 24 | $122.5M | $241.0M | ||
| Q3 24 | $112.2M | $225.5M | ||
| Q2 24 | $108.6M | $256.0M | ||
| Q1 24 | $79.9M | $263.4M |
净利润KNSARILY
| Q4 25 | $14.2M | $90.3M | ||
| Q3 25 | $18.4M | $91.1M | ||
| Q2 25 | $17.8M | $139.5M | ||
| Q1 25 | $8.5M | $-10.0M | ||
| Q4 24 | $-8.9M | $-5.6M | ||
| Q3 24 | $-12.7M | $-284.4M | ||
| Q2 24 | $-3.9M | $-433.6M | ||
| Q1 24 | $-17.7M | $-49.2M |
毛利率KNSARILY
| Q4 25 | 89.6% | 79.5% | ||
| Q3 25 | 88.8% | 83.7% | ||
| Q2 25 | 88.1% | 81.3% | ||
| Q1 25 | 87.0% | 81.4% | ||
| Q4 24 | 85.4% | 79.8% | ||
| Q3 24 | 82.1% | 82.1% | ||
| Q2 24 | 88.7% | 84.5% | ||
| Q1 24 | 86.7% | 85.3% |
营业利润率KNSARILY
| Q4 25 | 9.8% | 32.3% | ||
| Q3 25 | 13.3% | 30.4% | ||
| Q2 25 | 12.9% | 5.7% | ||
| Q1 25 | 9.6% | -31.2% | ||
| Q4 24 | -15.7% | -69.2% | ||
| Q3 24 | -8.6% | -36.4% | ||
| Q2 24 | -0.1% | -90.8% | ||
| Q1 24 | -20.7% | -6.1% |
净利率KNSARILY
| Q4 25 | 7.0% | 47.9% | ||
| Q3 25 | 10.2% | 42.3% | ||
| Q2 25 | 11.4% | 74.1% | ||
| Q1 25 | 6.2% | -5.1% | ||
| Q4 24 | -7.3% | -2.3% | ||
| Q3 24 | -11.3% | -126.1% | ||
| Q2 24 | -3.6% | -169.4% | ||
| Q1 24 | -22.2% | -18.7% |
每股收益（稀释后）KNSARILY
| Q4 25 | $0.18 | $2.78 | ||
| Q3 25 | $0.23 | $2.91 | ||
| Q2 25 | $0.23 | $4.50 | ||
| Q1 25 | $0.11 | $-0.39 | ||
| Q4 24 | $-0.11 | $-0.01 | ||
| Q3 24 | $-0.18 | $-9.39 | ||
| Q2 24 | $-0.06 | $-14.35 | ||
| Q1 24 | $-0.25 | $-1.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $414.1M | $226.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $567.6M | $-171.5M |
| 总资产 | $763.6M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资KNSARILY
| Q4 25 | $414.1M | $226.6M | ||
| Q3 25 | $352.1M | $184.2M | ||
| Q2 25 | $307.8M | $267.4M | ||
| Q1 25 | $268.3M | $138.3M | ||
| Q4 24 | $243.6M | $146.9M | ||
| Q3 24 | $223.8M | $159.2M | ||
| Q2 24 | $218.8M | $236.9M | ||
| Q1 24 | $213.6M | $190.7M |
总债务KNSARILY
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.4B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益KNSARILY
| Q4 25 | $567.6M | $-171.5M | ||
| Q3 25 | $535.4M | $-260.5M | ||
| Q2 25 | $495.0M | $-351.7M | ||
| Q1 25 | $457.5M | $-496.8M | ||
| Q4 24 | $438.4M | $-488.2M | ||
| Q3 24 | $437.0M | $-497.6M | ||
| Q2 24 | $435.1M | $-218.3M | ||
| Q1 24 | $431.9M | $228.4M |
总资产KNSARILY
| Q4 25 | $763.6M | $1.7B | ||
| Q3 25 | $712.3M | $1.7B | ||
| Q2 25 | $661.1M | $1.5B | ||
| Q1 25 | $599.3M | $1.5B | ||
| Q4 24 | $580.6M | $1.8B | ||
| Q3 24 | $555.3M | $2.2B | ||
| Q2 24 | $542.4M | $3.2B | ||
| Q1 24 | $519.7M | $5.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.9M | $26.2M |
| 自由现金流经营现金流 - 资本支出 | $53.3M | — |
| 自由现金流率自由现金流/营收 | 26.4% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | 3.80× | 0.29× |
| 过去12个月自由现金流最近4个季度 | $136.4M | — |
8季度趋势，按日历期对齐
经营现金流KNSARILY
| Q4 25 | $53.9M | $26.2M | ||
| Q3 25 | $33.7M | $-60.6M | ||
| Q2 25 | $28.1M | $-25.6M | ||
| Q1 25 | $22.3M | $184.0K | ||
| Q4 24 | $18.8M | $-2.7M | ||
| Q3 24 | $-2.2M | $19.5M | ||
| Q2 24 | $5.2M | $111.5M | ||
| Q1 24 | $4.0M | $135.4M |
自由现金流KNSARILY
| Q4 25 | $53.3M | — | ||
| Q3 25 | $33.0M | — | ||
| Q2 25 | $27.9M | — | ||
| Q1 25 | $22.2M | — | ||
| Q4 24 | $18.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $3.9M | — |
自由现金流率KNSARILY
| Q4 25 | 26.4% | — | ||
| Q3 25 | 18.2% | — | ||
| Q2 25 | 17.8% | — | ||
| Q1 25 | 16.1% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 4.9% | — |
资本支出强度KNSARILY
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
现金转化率KNSARILY
| Q4 25 | 3.80× | 0.29× | ||
| Q3 25 | 1.83× | -0.66× | ||
| Q2 25 | 1.58× | -0.18× | ||
| Q1 25 | 2.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
KNSA
暂无分部数据
RILY
| Transferred At Point In Time | $101.4M | 54% |
| Wealth Management Segment | $30.7M | 16% |
| Corporate Finance Consulting And Investment Banking Fees | $27.1M | 14% |
| Services And Fees | $24.8M | 13% |
| Commissions Fees And Reimbursed Expenses | $4.8M | 3% |
